+

WO2002000680A3 - Materiaux et procedes relatifs a l'administration de genes - Google Patents

Materiaux et procedes relatifs a l'administration de genes Download PDF

Info

Publication number
WO2002000680A3
WO2002000680A3 PCT/GB2001/002859 GB0102859W WO0200680A3 WO 2002000680 A3 WO2002000680 A3 WO 2002000680A3 GB 0102859 W GB0102859 W GB 0102859W WO 0200680 A3 WO0200680 A3 WO 0200680A3
Authority
WO
WIPO (PCT)
Prior art keywords
gene delivery
steroid derivatives
cationic steroid
head group
cationic
Prior art date
Application number
PCT/GB2001/002859
Other languages
English (en)
Other versions
WO2002000680A2 (fr
Inventor
Kam Man Hui
Hui Gao
Original Assignee
Ncc Technology Pte Ltd
Stuart Ian
Kam Man Hui
Hui Gao
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ncc Technology Pte Ltd, Stuart Ian, Kam Man Hui, Hui Gao filed Critical Ncc Technology Pte Ltd
Priority to AU2001266189A priority Critical patent/AU2001266189A1/en
Publication of WO2002000680A2 publication Critical patent/WO2002000680A2/fr
Publication of WO2002000680A3 publication Critical patent/WO2002000680A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/554—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Nouveaux lipides pour former des liposomes destinés à être utilisés comme véhicules pour administrer des acides nucléiques, p.ex. en thérapie génique; ils possèdent une structure avec une domaine stéroïde (cholestéryle) lié à travers une liaison carbamoyle à un groupe de tête qui est positivement chargé pendant l'utilisation (en règle générale, par protonation). Le groupe de tête comprend de préférence un hétérocycle d'azote, p.ex. un système de noyau pipérazine ou morpholine.
PCT/GB2001/002859 2000-06-26 2001-06-26 Materiaux et procedes relatifs a l'administration de genes WO2002000680A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001266189A AU2001266189A1 (en) 2000-06-26 2001-06-26 Materials and methods relating to gene delivery

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0015624.0A GB0015624D0 (en) 2000-06-26 2000-06-26 Materials and methods relating to improved gene delivery
GB0015624.0 2000-06-26

Publications (2)

Publication Number Publication Date
WO2002000680A2 WO2002000680A2 (fr) 2002-01-03
WO2002000680A3 true WO2002000680A3 (fr) 2002-05-16

Family

ID=9894419

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2001/002859 WO2002000680A2 (fr) 2000-06-26 2001-06-26 Materiaux et procedes relatifs a l'administration de genes

Country Status (3)

Country Link
AU (1) AU2001266189A1 (fr)
GB (1) GB0015624D0 (fr)
WO (1) WO2002000680A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10109898A1 (de) * 2001-02-21 2002-09-05 Novosom Gmbh Lipide mit veränderlicher Ladung
CN115487168A (zh) * 2022-09-27 2022-12-20 浙江大学 一种基于含氮杂环胆固醇衍生物的脂质纳米颗粒及其应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996018372A2 (fr) * 1994-12-09 1996-06-20 Genzyme Corporation Amphiphiles cationiques et plasmides destines a la liberation intracellulaire de molecules therapeutiques
WO1996040726A1 (fr) * 1995-06-07 1996-12-19 Genta Incorporated Nouveaux lipides cationiques a base de carbamate
WO1997004748A2 (fr) * 1995-08-01 1997-02-13 Advanced Therapies, Inc. Enveloppes virales artificielles renforcees pour l'apport de substances therapeutiques dans les cellules
WO1997039019A1 (fr) * 1996-04-12 1997-10-23 University Of Pittsburgh Nouveaux derives de cholesteryle cationiques contenant des groupes polaires cycliques
WO1998045317A1 (fr) * 1997-04-04 1998-10-15 Genzyme Corporation Amphiphiles cationiques contenant de l'imidazole, pour liberation intracellulaire de molecules therapeutiques

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996018372A2 (fr) * 1994-12-09 1996-06-20 Genzyme Corporation Amphiphiles cationiques et plasmides destines a la liberation intracellulaire de molecules therapeutiques
WO1996040726A1 (fr) * 1995-06-07 1996-12-19 Genta Incorporated Nouveaux lipides cationiques a base de carbamate
WO1997004748A2 (fr) * 1995-08-01 1997-02-13 Advanced Therapies, Inc. Enveloppes virales artificielles renforcees pour l'apport de substances therapeutiques dans les cellules
WO1997039019A1 (fr) * 1996-04-12 1997-10-23 University Of Pittsburgh Nouveaux derives de cholesteryle cationiques contenant des groupes polaires cycliques
WO1998045317A1 (fr) * 1997-04-04 1998-10-15 Genzyme Corporation Amphiphiles cationiques contenant de l'imidazole, pour liberation intracellulaire de molecules therapeutiques

Also Published As

Publication number Publication date
GB0015624D0 (en) 2000-08-16
AU2001266189A1 (en) 2002-01-08
WO2002000680A2 (fr) 2002-01-03

Similar Documents

Publication Publication Date Title
Vigneron et al. Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells.
Pichon et al. Histidylated oligolysines increase the transmembrane passage and the biological activity of antisense oligonucleotides
YU44404A (sh) Postupak za identifikovanje ciljnih enzima tumora
WO2002009769A3 (fr) Composes azoiques therapeutiques pour administration medicamenteuse
WO2004044132A3 (fr) Oligonucleotides modifies a utiliser dans l'interference de l'arn
HK1084941A1 (en) Compounds and their use
CA2266781A1 (fr) Cytofectines a base de piperazine
EP1142877A4 (fr) Composes de 2-oxoquinoline et leurs utilisations medicinales
BG106481A (en) Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumour agents
AU2002348163A1 (en) Therapeutic methods for nucleic acid delivery vehicles
WO2000065024A3 (fr) Micelles polymeriques hyperramifiees destinees a encapsuler et transporter des molecules hydrophobes
EP1191098A3 (fr) Composition pharmaceutique pour le traitement de la dystrophie musculaire de Duchenne
AU4180296A (en) Adjuvant for a vaccine composition
PT1530465E (pt) Processo para produção de uma preparação lipossomal catiónica que compreende um composto lipofílico
EP1201239A4 (fr) Antagonistes d'amine cyclique ccr3
GB2338484B (en) Medicaments comprising a nucleic acid encoding a cell targeting moiety and a prodrug activating enzyme
WO2000061543A3 (fr) Esters de l-carnitine ou de l-carnitines alcanoyles utilises comme lipides cationiques pour un apport intracellulaire de composes actifs d'un point de vue pharmacologique
Niyomtham et al. Synthesis and in vitro transfection efficiency of spermine-based cationic lipids with different central core structures and lipophilic tails
WO2005070466A3 (fr) Composition de liposomes pour l'administration d'agents therapeutiques
DK0734252T3 (da) Vincaalkaloidvesikler med forøget effektivitet og tumormålsøgningsegenskaber
AU3295700A (en) Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
WO2002000680A3 (fr) Materiaux et procedes relatifs a l'administration de genes
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
Islam et al. Efficient nucleic acid transduction with lipoplexes containing novel piperazine-and polyamine-conjugated cholesterol derivatives
EP1038896A3 (fr) Catalyseurs d'amine contenant une fonctionnalité amido pour la préparation de polyuréthanes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载